Evaluation of the Clinical and Genetic association between Myotonic Dystrophy Type 1 and Fuchs Endothelial Corneal Dystrophy

Overview

About this study

The purpose of this study is to test for a clinical and genetic association between Myotonic Dystrophy Type 1 (DM1) and Fuchs endothelial corneal dystrophy (FECD).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects with DM1 which is genetically proven or clinically diagnosedFamily members of subjects with DM1 who are affected or unaffected by the disease
  • Ability to understand and willingness to sign the informed consent documents
  • Age ≥18 yrs

Exclusion Criteria: 

  • Unable or unwilling to sign or understand the informed consent documents
  • Unwilling to participate in the research
  • Unwilling to allow genetic testing
  • Unwilling to allow samples to be sent to other institutions for testing
  • Not meeting the inclusion criteria

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Keith Baratz, M.D.

Open for enrollment

Contact information:

Hamad Gul

(507)284-5833

Gul.Hamad@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available